byiShook Opinion
Nov 26, 2024 - 11:05
Shares of Arrowhead Pharmaceuticals catapulted Tuesday after the company inked a broad licensing deal with Sarepta Therapeutics. The post Arrowhead Launches 25% On A Massive Licensing Deal With Sarepta appeared first on Investor's Business Daily.
Shares of Arrowhead Pharmaceuticals catapulted Tuesday after the company inked a broad licensing deal with Sarepta Therapeutics.
The post Arrowhead Launches 25% On A Massive Licensing Deal With Sarepta appeared first on Investor's Business Daily.